CLCS (Cell Source) Insider Ownership: 4.93 % (As of Jul. 09, 2026)


CLCS Cell Source Inc CLCS
35 GF Score
Price $0.95
View Full Analysis

What is Cell Source Insider Ownership?

Cell Source CLCS +6.65% 35 Insider Ownership is 4.93 % as of Jul. 09, 2026. GuruFocus rates CLCS with a GF Score™ of 35/100.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cell Source's insider ownership is 4.93%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cell Source's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cell Source's Float Percentage Of Total Shares Outstanding is 91.33%.

Cell Source Insider Ownership Historical Data

* Premium members only.

The historical data trend for Cell Source's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Source Insider Ownership Chart

Cell Source Historical Data

The historical data trend for Cell Source can be seen below:

2018-02-28 2018-03-31 2018-04-30 2018-05-31 2018-06-30 2018-07-31 2018-08-31 2018-09-30 2018-10-31 2018-11-30
Insider Ownership 5.12 5.12 5.12 5.12 5.12 5.12 4.93 4.93 4.93 4.93
CLCS
35GF Score
Cell Source Inc CLCS
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cell Source Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 4.93 % mean?
Cell Source (CLCS) has a Insider Ownership of 4.93 % as of Jul. 09, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Cell Source and its competitors.
Is Cell Source's Insider Ownership too high?
Cell Source's current Insider Ownership is 4.93 %. Overall, Cell Source has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Cell Source's Insider Ownership compare to EDSA and CTXR?
Cell Source's Insider Ownership of 4.93 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Cell Source and its competitors. Cell Source's current Insider Ownership is 4.93 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Source stock overvalued right now?
Cell Source (CLCS) has a current Insider Ownership of 4.93 %. The current Insider Ownership is 4.93 %. Cell Source's overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Cell Source (CLCS), the current Insider Ownership is 4.93 % as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cell Source Business Description

Address 57 West 57th Street, Suite 400, New York, NY, USA, 10019
Cell Source Inc is a biotechnology company focused on developing cell therapy treatments focused on immunotherapy. The company is involved with the development of proprietary immune system management technology. The company's subsidiary commercializes a suite of inventions relating to certain cancer treatments. The other products include Anti-rejection Veto Cell tolerance therapy for both matched and mismatched allogeneic bone marrow transplantations and Anti-rejection Veto Cell tolerance therapy for both matched as well as mismatched organ transplantation.
35GF Score

Get the complete analysis for CLCS

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.95
Price